Survival without severe neonatal morbidity after antenatal betamethasone dose reduction: a post-hoc analysis of randomised non-inferiority trial

Sunday, April 30, 2023

9:00 AM – 9:15 AM ET

Location: Convention Center: Ballroom A

Publication Number: 2150.5

Thomas Schmitz, Assistance Publique - Hôpitaux de Paris, Paris, Ile-de-France, France; Loic Sentilhes, Bordeaux University Hospital, Bordeaux, Aquitaine, France; Muriel Doret-Dion, Hospices civils de Lyon, Lyon, Rhone-Alpes, France; Moreno Ursino, APHP, Paris, Ile-de-France, France; Camille Aupiais, AdventHealth for Children, Bondy, Ile-de-France, France; olivier Baud, University of Geneva, Geneva, Geneve, Switzerland

Presenting Author(s)

Olivier Baud, MD, PhD
Ordinary professor
University of Geneva
Geneva, Geneve, Switzerland

Disclosure(s):

Thomas Schmitz, MD, PhD: Dilafor (Terminated, March 1, 2022) (Products/Services: Consultant)

Loic Sentilhes, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Muriel Doret-Dion, MD PHD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Moreno Ursino, PhD: Sanofi (Terminated, January 1, 2021) (Products/Services: Consultant)

Camille Aupiais, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

olivier baud, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.